These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 38177560

  • 21. The multidisciplinary management of cholangiocarcinoma.
    Ohaegbulam KC, Koethe Y, Fung A, Mayo SC, Grossberg AJ, Chen EY, Sharzehi K, Kardosh A, Farsad K, Rocha FG, Thomas CR, Nabavizadeh N.
    Cancer; 2023 Jan 15; 129(2):184-214. PubMed ID: 36382577
    [Abstract] [Full Text] [Related]

  • 22. Surgical management of cholangiocarcinoma.
    Jarnagin WR, Shoup M.
    Semin Liver Dis; 2004 May 15; 24(2):189-99. PubMed ID: 15192791
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cholangiocarcinoma.
    Mosconi S, Beretta GD, Labianca R, Zampino MG, Gatta G, Heinemann V.
    Crit Rev Oncol Hematol; 2009 Mar 15; 69(3):259-70. PubMed ID: 18977670
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Cholangiocarcinoma].
    Harder J, Blum HE.
    Praxis (Bern 1994); 2002 Aug 21; 91(34):1352-6. PubMed ID: 12233266
    [Abstract] [Full Text] [Related]

  • 29. Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.
    Luvira V, Satitkarnmanee E, Pugkhem A, Kietpeerakool C, Lumbiganon P, Pattanittum P.
    Cochrane Database Syst Rev; 2021 Sep 13; 9(9):CD012814. PubMed ID: 34515993
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunotherapy in Biliary Tract Cancers: Where Are We?
    Kalyan A, Khosla H, Kim RD.
    Curr Oncol Rep; 2022 Dec 13; 24(12):1821-1828. PubMed ID: 36192517
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular targeted and systemic therapy for intrahepatic cholangiocarcinoma: a multi-disciplinary approach.
    Merath K, Tiwari A, Parikh AA, Pawlik TM.
    Future Oncol; 2023 Dec 13; 19(39):2607-2621. PubMed ID: 38108100
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Durvalumab in advanced cholangiocarcinoma: is someone knocking down the door?
    Ricci AD, D'Alessandro R, Rizzo A, Schirizzi A, Vallarelli S, Ostuni C, Troiani L, Lolli IR, Lotesoriere C, Giannelli G.
    Immunotherapy; 2023 May 13; 15(7):477-486. PubMed ID: 36950960
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment.
    Cosgrove DP, Reese ES, Fulcher NM, Bobiak SS, Lamy FX, Allignol A, Boyd M, Mahmoudpour SH.
    Cancer Med; 2023 Feb 13; 12(4):4195-4205. PubMed ID: 36263922
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.